Do CD16+NKG2A+NK Cells Recruited to the Gut Combined with Passively Administered SIV Specific Antibodies Prevent SIV(mac251) Acquisition in Macaques?

Documenti analoghi

• Antiretroviral Therapy Partly Reverses the Systemic and Mucosal Distribution of NK Cell Subsets that is Altered by SIV(mac251) Infection of Macaques
  di: Liyanage, Namal P. M., et al.
  Pubblicazione: (2014)
• Adjuvant-dependent innate and adaptive immune signatures of risk of SIV(mac251) acquisition
  di: Vaccari, Monica, et al.
  Pubblicazione: (2016)
• Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIV(mac251) Acquisition
  di: Gordon, Shari N., et al.
  Pubblicazione: (2016)
• Glucocorticoid Treatment at Moderate Doses of SIV(mac251)-Infected Rhesus Macaques Decreases the Frequency of Circulating CD14(+)CD16(++) Monocytes But Does Not Alter the Tissue Virus Reservoir
  di: Moniuszko, Marcin, et al.
  Pubblicazione: (2015)
• Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIV(mac251) Acquisition
  di: Vaccari, Monica, et al.
  Pubblicazione: (2014)